Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Bambusa Therapeutics operates as biotechnology company.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
EmployerDirect Healthcare is a supplemental healthcare benefit that directs planned medical procedures to high-quality providers.
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Medical documentation, Point-of-care notifications, Structured data, Open ecosystem
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.
Redmile Group has invested in 105 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Redmile Group's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 19 different industry categories.
Among tracked funding rounds, ElevateBio received $401.0M in a Series D round. Redmile Group's total known invested capital is $12.6B.
Redmile Group's average investment size is $119.9M across its portfolio of 105 companies.
Recent Redmile Group portfolio additions include Rapt Therapeutics, ADC Therapeutics, Strand Therapeutics, Prime Medicine, Quantum SI. These companies were founded in 2020 or later.